Interleukin-6 Receptor Blockade Enhances CD39+ Regulatory T Cell Development in Rheumatoid Arthritis and in Experimental Arthritis-Reference-Cited by-同舟云学术

Interleukin-6 Receptor Blockade Enhances CD39+ Regulatory T Cell Development in Rheumatoid Arthritis and in Experimental Arthritis

Published:2014-01-27 Issue:2 Volume:66 Page:273-283
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Thiolat A.¹,Semerano L.²,Pers Y. M.³,Biton J.¹,Lemeiter D.¹,Portales P.⁴,Quentin J.⁵,Jorgensen C.³,Decker P.¹,Boissier M.-C.²,Louis-Plence P.⁵,Bessis N.¹

Affiliation:

1. INSERM U1125 and Sorbonne Paris Cité Université Paris 13; Bobigny France

2. INSERM U1125, Sorbonne Paris Cité Université Paris 13, and AP-HP; Bobigny France

3. INSERM U844, Université Montpellier 1, and CHU Hôpital Lapeyronie; Montpellier France

4. Hopital Saint-Eloi; Montpellier France

5. INSERM U844 and Université Montpellier 1; Montpellier France

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Reference48 articles.

1. Interleukin 6 is required for the development of collagen-induced arthritis;Alonzi;J Exp Med,1998

2. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis;Takagi;Arthritis Rheum,1998

3. Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity;Madhok;Ann Rheum Dis,1993

4. Advances in rheumatology: new targeted therapeutics;Tak;Arthritis Res Ther,2011

5. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells;Dienz;J Exp Med,2009

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transiently increased circulating CD39+FoxP3+ Treg cells predicts the clinical response to methotrexate in early rheumatoid arthritis;Rheumatology;2024-08-14

2. Discovery and preclinical evaluation of KYS202004A, a novel bispecific fusion protein targeting TNF-α and IL-17A, in autoimmune disease models;International Immunopharmacology;2024-07

3. Fibroblast: A Novel Target for Autoimmune and Inflammatory Skin Diseases Therapeutics;Clinical Reviews in Allergy & Immunology;2024-06-28

4. IL-6 Inhibition as a Therapeutic Target in Aged Experimental Autoimmune Encephalomyelitis;International Journal of Molecular Sciences;2024-06-19

5. Augmenting regulatory T cells: new therapeutic strategy for rheumatoid arthritis;Frontiers in Immunology;2024-01-23